X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Elder Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ADCOCK INGRAM
Jun-14
ELDER PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs380352-   
Low Rs188254-   
Sales per share (Unadj.) Rs491.2104.8-  
Earnings per share (Unadj.) Rs-3.2-26.4-  
Cash flow per share (Unadj.) Rs14.4-21.9-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.582.3-  
Shares outstanding (eoy) m20.54168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.9 20.0%   
Avg P/E ratio x-89.3-11.5 777.4%  
P/CF ratio (eoy) x19.7-13.9 -142.3%  
Price / Book Value ratio x0.83.7 20.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83351,185 11.4%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,1793,212 67.8%   
Avg. sales/employee Rs ThNM4,120.8-  
Avg. wages/employee Rs ThNM748.3-  
Avg. net profit/employee Rs ThNM-1,038.3-  
INCOME DATA
Net Sales Rs m10,08917,690 57.0%  
Other income Rs m257124 207.1%   
Total revenues Rs m10,34617,814 58.1%   
Gross profit Rs m-792-3,066 25.8%  
Depreciation Rs m361764 47.3%   
Interest Rs m2,756479 575.2%   
Profit before tax Rs m-3,653-4,184 87.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125261 47.9%   
Profit after tax Rs m-65-4,458 1.5%  
Gross profit margin %-7.8-17.3 45.3%  
Effective tax rate %-3.4-6.2 54.8%   
Net profit margin %-0.6-25.2 2.6%  
BALANCE SHEET DATA
Current assets Rs m9,24012,957 71.3%   
Current liabilities Rs m9,9987,290 137.1%   
Net working cap to sales %-7.532.0 -23.4%  
Current ratio x0.91.8 52.0%  
Inventory Days Days46111 41.8%  
Debtors Days Days60124 48.4%  
Net fixed assets Rs m10,1247,552 134.0%   
Share capital Rs m20682 250.4%   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,73413,885 55.7%   
Long term debt Rs m4,8894,879 100.2%   
Total assets Rs m22,88226,230 87.2%  
Interest coverage x-0.3-7.7 4.2%   
Debt to equity ratio x0.60.4 179.9%  
Sales to assets ratio x0.40.7 65.4%   
Return on assets %11.8-15.2 -77.5%  
Return on equity %-0.8-32.1 2.6%  
Return on capital %22.3-19.8 -112.6%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,7541,510 778.4%  
From Investments Rs m-561-464 120.9%  
From Financial Activity Rs m-6,7624,428 -152.7%  
Net Cashflow Rs m4,4325,475 80.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.86 Rs / ZAR

Compare ELDER PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  CIPLA  JUBILANT LIFE SCIENCES  STRIDES SHASUN LTD  



Today's Market

Sensex, Nifty Close at Record Highs; Healthcare and Power Stocks Witness Buying(Closing)

Indian share markets continued to trade on a flat during closing hours of trade and ended the day marginally higher to close at fresh record high levels.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

3 Reasons Why I Believe This Company Can Make It Big!(The 5 Minute Wrapup)

Aug 16, 2018

How consumer-facing businesses can multiply your wealth in the coming years.

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Economic Growth was Faster During Manmohan Years Than Modi Years, But...(Vivek Kaul's Diary)

Aug 20, 2018

When it comes to the economy, both Modi and Manmohan have had their share of major screw ups.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

To Identify Pricing Power, Compare Companies Like This(Chart Of The Day)

Aug 10, 2018

Pricing power is the first tenet of an economic moat. If you see that in a company, do investigate to find an economic moat.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS